News

Dr. Athos Patsalides is now enrolling patients in a Phase I research study on spinal metastatic disease (SMD). This new trial will test the safety of a new minimally invasive treatment called spinal intra-arterial chemotherapy (SIAC) in patients with SMD.

As many as 10 percent of cancer patients will develop a metastatic spinal tumor during the course of their disease — metastasis from another cancer is the most common cause of malignant spinal tumors in adults. The most devastating...

Neurosurgeon Dr. Theodore Schwartz, along with Dr. Chris Schaffer of Biomedical Engineering at Cornell University in Ithaca, has received a prestigious 2-year NIH grant to lead research on ground-breaking laser treatments for epilepsy. In his lab at the Weill Cornell Brain and Spine Center, Dr. Schwartz will use a femtosecond laser on animal models to make microscopic incisions in portions of the brain in hopes to prevent epileptic seizures yet preserve function.

The goal of the...

Dr. Mark Souweidane will co-lead a three-day endoscopic neurosurgery course this spring in Germany with Dr. Peter Nakaji of Barrow Neurological Associates. The course will offer a comprehensive overview on endoscopic techniques in intracranial neurosurgery, including didactic lectures, illustrative cases, and cadaveric workshop sessions. Procedures will include managing complex hydrocephalus, removing intraventricular tumors, and endoscopic transnasal approaches to the pituitary fossa and...